Most concluded that the substance appears quite promising, but that there are too many unknowns to justify its clinical use at this time
Investigated applications In the published research literature, effects of Melanotan II are documented in the following areas: Photoprotection and melanogenesis , robustly demonstrated, the original indication Hypoactive sexual desire disorder , via the derivative Bremelanotide, FDA-approved 2019 Erectile dysfunction , exploratory in animal and human models Obesity and appetite , preclinical models (MC4R mechanism) Erythropoietic protoporphyria , via the derivative Afamelanotide, approved 2014 Acne vulgaris , paradoxically, MC5R activation may worsen it Vitiligo , exploratory in dermatological research Ischemic neuroprotection , developing preclinical research Pro-inflammatory pathways , via MC3R activation Buying Melanotan II: what to look for When buying Melanotan II , the decisive criterion is not the price but the verifiability of quality
0% with placebo, suggesting promising early efficacy signals [49]
I found this great website that directed me to just the right place, where Dr
Metellus is with Geisinger Commonwealth School of Medicine in Scranton, Pennsylvania